Eric Mayer is the President and Chief Executive Officer. He has been the Chief Executive Officer of the Company since 2015 and now serves on the Board of Directors. Eric Mayer had previously served as Vice President of Business Development of New Day Biotech since 2013 overseeing various aspects of product development, intellectual property, and forming alliances with manufacturing partners. Prior to this, Eric Mayer directed business development at BioPet Vet Lab resulting in the market launch, distribution, and subsequent revenue growth of BioPet’s primary genetic product. His experiences include nearly a decade of start-up biotech involvement with diagnostic firms such as AAD, Inc., and research companies such as Metabolon, Inc. and Cirrus Pharmaceuticals. He received his Bachelor’s in Biochemistry from UNC-Chapel Hill, and his Master’s of Microbial Biotechnology and Master’s of Business Administration from North Carolina State University.